ASTH — APOLLO MED HLDGS INC

Ownership history in ProShare Advisors LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which ProShare Advisors LLC reported a position in APOLLO MED HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 7,724 -1,397 -15.3% 0.00% $219K $28.35
2025 Q2 REDUCED 9,121 -999 -9.9% 0.00% $227K $24.88
2025 Q1 REDUCED 10,120 -2,836 -21.9% 0.00% $314K $31.01
2024 Q4 ADDED 12,956 +3,996 +44.6% 0.00% $409K $31.53
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ASTH price (monthly, adj. close)

Other funds also holding ASTH

As of 2025 Q4 — sorted by position size

325 CAPITAL LLC 3Y 15.99% 1492 Capital Management LLC 3Y 7Y 1.59% QSV Equity Investors LLC 1.09% SteelPeak Wealth, LLC 3Y 0.47% Insight Wealth Strategies, LLC 3Y 7Y 0.4% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.38% Shay Capital LLC 3Y 0.31% Capstone Capital Management Ltd 0.28% NorthCrest Asset Manangement, LLC 3Y 0.28% ROYCE & ASSOCIATES LP 3Y 7Y 0.09%
← Back to ProShare Advisors LLC Holdings